Cargando…
Targeting lncRNA PSMA3-AS1, a Prognostic Marker, Suppresses Malignant Progression of Oral Squamous Cell Carcinoma
OBJECTIVE: Oral squamous cell carcinoma (OSCC) represents the most common maxillofacial malignancy. This study elucidated the clinicopathological value and molecular mechanisms of PSMA3 antisense RNA 1 (PSMA3-AS1) in OSCC. METHODS: Totally, 135 OSCC patients were recruited. PSMA3-AS1 expression and...
Autores principales: | Cao, Xinghua, Luan, Kefeng, Yang, Jie, Huang, Yundong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397548/ https://www.ncbi.nlm.nih.gov/pubmed/34457087 http://dx.doi.org/10.1155/2021/3138046 |
Ejemplares similares
-
LncRNA PVT1 promotes malignant progression in squamous cell carcinoma of the head and neck
por: Yu, Changyun, et al.
Publicado: (2018) -
LncRNA HOXA-AS2 Promotes Tumor Progression by Suppressing miR-567 Expression in Oral Squamous Cell Carcinoma
por: Chen, Rui, et al.
Publicado: (2021) -
Prognostic signature related to the immune environment of oral squamous cell carcinoma
por: Hua, Yingjie, et al.
Publicado: (2022) -
Serum lncRNA THRIL predicts benign and malignant pulmonary nodules and promotes the progression of pulmonary malignancies
por: Chen, Xinyu, et al.
Publicado: (2023) -
Prognostic significance of a 4-lncRNA glycolysis-related signature in oral squamous cell carcinoma
por: Wu, Liangyin, et al.
Publicado: (2022)